<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00532766</url>
  </required_header>
  <id_info>
    <org_study_id>CMRC06-535</org_study_id>
    <nct_id>NCT00532766</nct_id>
  </id_info>
  <brief_title>Evaluating Pharmacokinetics and Pharmacodynamics of Jusline</brief_title>
  <official_title>Bioequivalence of Jusline Following Subcutaneous Administration in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Saud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Saud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline)
      after subcutaneous administration, and to compare this profile with Humulin insulin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline)
      after subcutaneous administration in the abdominal, and to compare this profile with Humulin
      insulin for three different preparations (Regular, NPH, and Premixed Regular/NPH (30/70)).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">February 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline)</measure>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Jusline Humulin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Jusline</intervention_name>
    <arm_group_label>2</arm_group_label>
    <other_name>Humulin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Non-diabetic

          -  Age 18-35 year

          -  Normal body mass index (BMI 18-25 kg/m2)

        Exclusion Criteria:

          -  Diabetics

          -  Overweight/obese

          -  Anemic, with liver, cardiac, renal or thyroid dysfunction
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khalid A Al-Rubeaan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>College of Medicine, King Saud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Diabetes Center</name>
      <address>
        <city>Riyadh</city>
        <zip>11461</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2007</study_first_submitted>
  <study_first_submitted_qc>September 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2007</study_first_posted>
  <last_update_submitted>September 24, 2007</last_update_submitted>
  <last_update_submitted_qc>September 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2007</last_update_posted>
  <keyword>Healthy subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

